Theralase Technologies Inc
XTSX:TLT
Theralase Technologies Inc
XTSX:TLT
Price:
0.16 CAD
Market Closed
Updated:
May 6, 2024
Theralase Technologies Inc
Cash from Investing Activities
|
Theralase Technologies Inc
Cash from Investing Activities Peer Comparison
Comparables:
NVCN
PRN
OPS
NSCI
MIR
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Theralase Technologies Inc
XTSX:TLT
|
Cash from Investing Activities
-CA$37.3k
|
CAGR 3-Years
39%
|
CAGR 5-Years
23%
|
CAGR 10-Years
8%
|
|
|
Neovasc Inc
TSX:NVCN
|
Cash from Investing Activities
-$52.5k
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Profound Medical Corp
TSX:PRN
|
Cash from Investing Activities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Opsens Inc
TSX:OPS
|
Cash from Investing Activities
-CA$1.9m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-13%
|
|
|
Nanalysis Scientific Corp
XTSX:NSCI
|
Cash from Investing Activities
-CA$11.7m
|
CAGR 3-Years
-55%
|
CAGR 5-Years
-68%
|
CAGR 10-Years
N/A
|
|
|
MedMira Inc
XTSX:MIR
|
Cash from Investing Activities
-CA$3.8k
|
CAGR 3-Years
67%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
36%
|
See Also
What is Theralase Technologies Inc's Cash from Investing Activities?
Cash from Investing Activities
-37.3k
CAD
-37.3k
CAD
Based on the financial report for Dec 31, 2023, Theralase Technologies Inc's Cash from Investing Activities amounts to -37.3k CAD.
What is Theralase Technologies Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
8%
8%
Over the last year, the Cash from Investing Activities growth was 47%. The average annual Cash from Investing Activities growth rates for Theralase Technologies Inc have been 39% over the past three years , 23% over the past five years , and 8% over the past ten years .
You don't have any saved screeners yet
